2023-01-09 - Cancer Synoptic Reporting Project Group Meeting

1. Need references
   
   
2. Questions:
   1. When is a #plasia generalized vs. localized (i.e., by organ)

Scott Campbell will draft a "blurb" and pathologists on the call will provide appropriate citations.

1/9/2023 - HG dysplasia vs. CIS.

Discussed the use of HG dysplasia, carcinoma in situ (CIS), and the and/or version.  This needs to be reviewed as the and/or for lymphovascular invasion body structure does not look correct for subsumption and classification.  GCIs may not be possible as they need defining attributes.

RE: #plasias.  Thomas Ruediger  supports a single set of morphologic abnormality concepts for glandular dysplasia, glandular intraepithelial neoplasia, squamous dysplasia, intraepithelial squamous neoplasia that are completely organ agnostic.

@ stefandubois suggests that such a conflation of concepts will require a comprehensive review by organ system.

In my opinion, both are correct.  This dovetails nicely into the Histology QI project.

The CSRWG needs to address what needs to/can be done to get the synoptic reporting content deliverable in the shorter term while also addressing the longer term Histology QI issue.

1. Async?  Out of sync

1. requests from Elze de Groot

Scott Campbell meeting with Nictiz on Friday, 1/16/23

1. Looking for interested parties

1. Documents of SNOMED CT terminology binding across major protocol producers

1. In person/mixed